Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Cardiac Resynchronization Therapy (CRT) Is an Effective Treatment for Heart Failure and Indications Are Expanding Multiple trials have shown the clinical value of CRT: decreased mortality, improved quality of life, and reduced hospitalizations.1-5 Today, more patients than ever are available to receive a CRT device and benefit from this therapy. 郭航远 绍兴市人民医院 1 2 Cleland JG, et al. N Engl J Med. 2005;352:1539-1549. Cleland JG, et al. Eur Heart J. 2006;27:1928-1932. 3 Bristow MR, et al. J Card Fail. 2000;6:276-285. Abraham WT, et al. N Engl J Med. 2002;346:1845-1853. 5 Young JB, et al. JAMA. 2003;289:2685-2694. 4 1 CRT Is Highly Beneficial1-8 CRT is an effective treatment for heart failure patients with: • systolic dysfunction • ventricular electrical conduction delays Mortality HF or CV Hospitalizations Cardiac Function/ Structure QoL or NYHA CARE-HF1,2 + + + NA COMPANION3 + + NA NA MIRACLE4 NA NA + + MIRACLE ICD5 NA NA NA + REVERSE6 NA +* + = RAFT7 + + NA NA MADIT CRT8 +* + +* NA NA = Not powered, not collected, or not blinded for specific end point. 1 2 3 4 Cleland J, et al. N Engl J Med. 2005;352:1539-1549. Cleland J, et al. Eur Heart J. 2006;27:1928-1932. Bristow M, et al. J Card Fail. 2000;6:276-285. Abraham W, et al. N Engl J Med. 2002;346:1845-1853. * Post-hoc analysis. 5 Young J, et al. JAMA. 2003;289:2685-2694. Linde C, et al. JACC. 2008;52:1834-1843. 7 Tang A, et al. N Engl J Med. 2010;363:2385-2395. 8 Moss A, et al. N Engl J Med. 2009;361:1329-1338. 6 2 Number of Patients Receiving CRT May Increase in Coming Years Due to: • Expansion of indications for CRT-D devices to NYHA Class II1-3* • Under-penetration of current NYHA Class III/IV indications4,5 * Indications for CRT-D devices include "Left bundle branch block (LBBB) with a QRS duration ≥ 130 ms, left ventricular ejection fraction ≤ 30%, and NYHA Functional Class II" 1 2 Tracy CM, et al. Circulation. 2012;126:1784-1800. Tang AS, et al. N Engl J Med. 2010;363:2385-2395. 3 Linde C, et al. J Am Coll Cardiol. 2008;52:1834-1843. Epstein AE, et al. Circulation. 2008;117:e350-e408. 5 Fonarow GC, et al. Circ Heart Fail. 2008;1:98-106. 4 3 Current Challenges with CRT Unpredictable CRT Implant Times CRT Challenges Suboptimal CRT Response 4 Clinical & Economic Need: CRT Implants Are Complex and Time-Consuming Initial CRT Device Implants (N=870)1 1 PPDA Q3FY12/Q4FY12/Q1FY13/Q2FY13 - (Waves 1-4): Economic Considerations for CRT Implants 5 Clinical & Economic Need: Placing the LV Lead Is Time-Consuming 1 2 PPDA Q4FY12/Q1FY13 - (Waves 2 and 3): Economic Considerations for CRT Implants. Bax JJ, et al. J Am Coll Cardiol. 2005;46:2168-2182. 6 Current Challenges with CRT Unpredictable CRT Implant Times CRT Challenges Suboptimal CRT Response 7 Up to 1/3 of Patients Do Not Experience the Full Benefits of CRT 100% 90% % Improved Clinical Composite Score 80% 70% 60% 67% 67% 69% 67% 58% 50% 52% 40% 30% 20% 10% 0% MIRACLE1 MIRACLE ICD2 MIRACLE II ICD3 1 4 2 5 Abraham WT, et al. N Engl J Med. 2002;346:1845-1853. Young JB, et al. JAMA. 2003;289:2685-2694. 3 Abraham WT, et al. Circulation 2004;110:2864-2868. InSync III Marquis4™* PROSPECT 5 FREEDOM6 * AV optimized only Chung ES, et al. Circulation. 2008;117:2608-2616. van Gelder BM, et al. J Cardiovasc Electrophysiol. 2008;19:939-944. 6 Abraham WT, et al. Late-Breaking Clinical Trials, HRS 2010. Denver, Colorado. 8 There Are Many Drivers for CRT Non-Response1 Potential Reasons for Suboptimal CRT Response Percentage of Nonresponder Patients with These Findings 50% 45% 40% 35% 30% 25% 20% 15% 10% 5% 0% Suboptimal AV Timing Arrhythmia Anemia Suboptimal LV Lead Position < 90% Suboptimal Persistent Underlying Biventricular Medical Mechanical Narrow Pacing Therapy Dyssynchrony QRS Compliance Primary RV Issues Dysfunction Mullens W, et al. JACC. 2009;53:765-773. Achieving maximum CRT response requires a multi-disciplinary approach 1 Mullens W, et al. J Am Coll Cardiol. 2009;53:765-773. 9 Economic Impact Lab Capacity Length of Stay1 Unpredictable CRT Implant Times Staff Overtime CRT Challenges Suboptimal CRT Response 1 Cost information from 2010 Premier hospital database analyzing 108,982 Inpatient Heart Failure Admissions (Abstract Submission to ISPOR and AHA QCOE, to be presented in July 2013). Supply Usage HF Hospital Admissions1 10 Real-Time Navigation for CRT Implants The CardioGuide™ Implant System Provides a Solution The CardioGuide Implant System – the first real-time navigation system for CRT implants – uses computer technologies to guide implanters in optimal LV lead placement. The system generates 3D images of coronary vessels to help clinicians: • Find appropriate LV lead locations • Identify proper lead delivery tools • Confirm final lead position 11 12 12 CardioGuide 3D System: Optimize LV Lead Implant Shoot 2+ venograms Trace veins of interest on both venograms Obtain 3D model automatically Understand and Examine Vein Anatomy 13 CardioGuide 3D System: Optimize LV Lead Implant Select preferred target site and choose LV lead Navigate real-time in fluoro Obtain anatomical information about target & match best lead Detect where lead is & how far from target 14 CardioGuide M-Map System: Drive for Full Benefit of CRT Obtain contraction timing maps along veins Select most appropriate delayed site and choose LV lead Identify latest site(s) of mechanical activation 15 Drive for Full Benefit of CRT • 1 2 Helping clinicians choose the proper lead location and providing confirmation of final lead position may impact CRT procedure efficiency and the economic welfare of the hospital.1-4 Giannola G, et al. Europace. 2011;13:244-250. Khan FZ, et al. Europace. 2011;13:845-852. 3 4 Khan FZ, et al. J Am Coll Cardiol. 2012;59:1509-1518. Prinzen FW, et al. J Cardiovasc Transl Res. 2012;5:188-195. 16 Thank You 17